Search
for
Sort by
Research 181–210 of 1000+
- Insulin Resistance and Skin Diseases
- Dermatology of androgen-related disorders
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Female Pattern Hair Loss
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Is polycystic ovary syndrome a sexual conflict? A review
- PCOS: update and diagnostic approach
- Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- The Evaluation and Management of Hirsutism
- Polycystic ovary syndrome: a dermatologic approach
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Hyperandrogenism in PCOS
- How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities
- May AMH levels distinguish LOCAH from PCOS among hirsute women?
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Caring for women with polycystic ovary syndrome
- Androgen-Related Alopecia and Infertility: Impact of Lifestyle Modifications
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Evaluation of patients with polycystic ovarian syndrome at a tertiary care center
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Polycystic Ovary Syndrome in Adolescents
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Obesity and the skin
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Elevated Free Testosterone Levels in Women With Acne
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition